{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T20:43:04Z","timestamp":1781901784177,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"S1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Pharmacological interactions are useful for understanding ligand binding mechanisms of a therapeutic target. These interactions are often inferred from a set of active compounds that were acquired experimentally. Moreover, most docking programs loosely coupled the stages (binding-site and ligand preparations, virtual screening, and post-screening analysis) of structure-based virtual screening (VS). An integrated VS environment, which provides the friendly interface to seamlessly combine these VS stages and to identify the pharmacological interactions directly from screening compounds, is valuable for drug discovery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We developed an easy-to-use graphic environment, <jats:italic>i<\/jats:italic> GEMDOCK, integrating VS stages (from preparations to post-screening analysis). For post-screening analysis, <jats:italic>i<\/jats:italic> GEMDOCK provides biological insights by deriving the pharmacological interactions from screening compounds without relying on the experimental data of active compounds. The pharmacological interactions represent conserved interacting residues, which often form binding pockets with specific physico-chemical properties, to play the essential functions of a target protein. Our experimental results show that the pharmacological interactions derived by <jats:italic>i<\/jats:italic> GEMDOCK are often hot spots involving in the biological functions. In addition, <jats:italic>i<\/jats:italic> GEMDOCK provides the visualizations of the protein-compound interaction profiles and the hierarchical clustering dendrogram of the compounds for post-screening analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>We have developed <jats:italic>i<\/jats:italic> GEMDOCK to facilitate steps from preparations of target proteins and ligand libraries toward post-screening analysis. <jats:italic>i<\/jats:italic> GEMDOCK is especially useful for post-screening analysis and inferring pharmacological interactions from screening compounds. We believe that <jats:italic>i<\/jats:italic> GEMDOCK is useful for understanding the ligand binding mechanisms and discovering lead compounds. <jats:italic>i<\/jats:italic> GEMDOCK is available at <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/gemdock.life.nctu.edu.tw\/dock\/igemdock.php\" ext-link-type=\"uri\">http:\/\/gemdock.life.nctu.edu.tw\/dock\/igemdock.php<\/jats:ext-link>.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2105-12-s1-s33","type":"journal-article","created":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T20:13:08Z","timestamp":1298059988000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":395,"title":["iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis"],"prefix":"10.1186","volume":"12","author":[{"given":"Kai-Cheng","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Fu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen-Rong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinn-Moon","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,15]]},"reference":[{"key":"4391_CR1","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S1359-6446(02)02483-2","volume":"7","author":"PD Lyne","year":"2002","unstructured":"Lyne PD: Structure-based virtual screening: an overview. Drug Discovery Today 2002, 7: 1047\u20131055. 10.1016\/S1359-6446(02)02483-2","journal-title":"Drug Discovery Today"},{"key":"4391_CR2","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nrd2615","volume":"7","author":"Y Tanrikulu","year":"2008","unstructured":"Tanrikulu Y, Schneider G: Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening. Nature Reviews Drug Discovery 2008, 7: 667\u2013677. 10.1038\/nrd2615","journal-title":"Nature Reviews Drug Discovery"},{"key":"4391_CR3","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nrd1549","volume":"3","author":"DB Kitchen","year":"2004","unstructured":"Kitchen DB, Decornez H, Furr JR, Bajorath J: Docking and scoring in virtual screening for drug discovery: methods and applications. Nature Reviews Drug Discovery 2004, 3: 935\u2013949. 10.1038\/nrd1549","journal-title":"Nature Reviews Drug Discovery"},{"key":"4391_CR4","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/prot.20035","volume":"55","author":"J-M Yang","year":"2004","unstructured":"Yang J-M, Chen C-C: GEMDOCK: a generic evolutionary method for molecular docking. Proteins 2004, 55: 288\u2013304. 10.1002\/prot.20035","journal-title":"Proteins"},{"key":"4391_CR5","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO;2-8","volume":"37","author":"B Kramer","year":"1999","unstructured":"Kramer B, Rarey M, Lengauer T: Evaluation of the flexX incremental construction algorithm for protein-ligand docking. Proteins 1999, 37: 228\u2013241. 10.1002\/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO;2-8","journal-title":"Proteins"},{"key":"4391_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/BF00124499","volume":"10","author":"GM Morris","year":"1996","unstructured":"Morris GM, Goodsell DS, Huey R, Olson AJ: Distributed automated docking of flexible ligands to proteins: parallel applications of AutoDock 2.4. Journal of Computer-Aided Molecular Design 1996, 10: 293\u2013304. 10.1007\/BF00124499","journal-title":"Journal of Computer-Aided Molecular Design"},{"key":"4391_CR7","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","volume":"267","author":"G Jones","year":"1997","unstructured":"Jones G, Willett P, Glen RC, Leach AR, Taylor R: Development and validation of a genetic algorithm for flexible docking. Journal of Molecular Biology 1997, 267: 727\u2013748. 10.1006\/jmbi.1996.0897","journal-title":"Journal of Molecular Biology"},{"issue":"2","key":"4391_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/prot.20387","volume":"59","author":"JM Yang","year":"2005","unstructured":"Yang JM, Shen TW: A pharmacophore-based evolutionary approach for screening selective estrogen receptor modulators. Proteins 2005, 59(2):205\u2013220. 10.1002\/prot.20387","journal-title":"Proteins"},{"key":"4391_CR9","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1021\/jm051112+","volume":"49","author":"A Tafi","year":"2006","unstructured":"Tafi A, Bernardini C, Botta M, Corelli F, Andreini M, Martinelli A, Ortore G, Baraldi PG, Fruttarolo F, Borea PA, et al.: Pharmacophore based receptor modeling: the case of adenosine A3 receptor antagonists. An approach to the optimization of protein models. Journal of Medicinal Chemistry 2006, 49: 4085\u20134097. 10.1021\/jm051112+","journal-title":"Journal of Medicinal Chemistry"},{"key":"4391_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.drudis.2007.09.007","volume":"13","author":"G Wolber","year":"2008","unstructured":"Wolber G, Seidel T, Bendix F, Langer T: Molecule-pharmacophore superpositioning and pattern matching in computational drug design. Drug Discovery Today 2008, 13: 23\u201329. 10.1016\/j.drudis.2007.09.007","journal-title":"Drug Discovery Today"},{"key":"4391_CR11","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.1371\/journal.pone.0000428","volume":"2","author":"JM Yang","year":"2007","unstructured":"Yang JM, Chen YF, Tu YY, Yen KR, Yang YL: Combinatorial computational approaches to identify tetracycline derivatives as flavivirus inhibitors. PLoS One 2007, 2: e428. 10.1371\/journal.pone.0000428","journal-title":"PLoS One"},{"key":"4391_CR12","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.jmb.2009.11.076","volume":"396","author":"KH Chin","year":"2010","unstructured":"Chin KH, Lee YC, Tu ZL, Chen CH, Tseng YH, Yang JM, Ryan RP, McCarthy Y, Dow JM, Wang AH, et al.: The cAMP receptor-like protein CLP is a novel c-di-GMP receptor linking cell-cell signaling to virulence gene expression in Xanthomonas campestris. Journal of Molecular Biology 2010, 396: 646\u2013662. 10.1016\/j.jmb.2009.11.076","journal-title":"Journal of Molecular Biology"},{"key":"4391_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.antiviral.2008.10.006","volume":"81","author":"HC Hung","year":"2009","unstructured":"Hung HC, Tseng CP, Yang JM, Ju YW, Tseng SN, Chen YF, Chao YS, Hsieh HP, Shih SR, Hsu JT: Aurintricarboxylic acid inhibits influenza virus neuraminidase. Antiviral Research 2009, 81: 123\u2013131. 10.1016\/j.antiviral.2008.10.006","journal-title":"Antiviral Research"},{"key":"4391_CR14","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1021\/cg800697s","volume":"8","author":"M-C Yang","year":"2008","unstructured":"Yang M-C, Guan H-H, Yang J-M, Ko C-N, Liu M-Y, Lin Y-H, Chen C-J, Mao SJT: Rational design for crystallization of beta-lactoglobulin and vitamin D-3 complex: revealing a secondary binding site. Crystal Growth & Design 2008, 8: 4268\u20134276. 10.1021\/cg800697s","journal-title":"Crystal Growth & Design"},{"key":"4391_CR15","doi-asserted-by":"publisher","first-page":"21862","DOI":"10.1074\/jbc.M200764200","volume":"277","author":"A Warnmark","year":"2002","unstructured":"Warnmark A, Treuter E, Gustafsson JA, Hubbard RE, Brzozowski AM, Pike AC: Interaction of transcriptional intermediary factor 2 nuclear receptor box peptides with the coactivator binding site of estrogen receptor alpha. Journal of Biological Chemistry 2002, 277: 21862\u201321868. 10.1074\/jbc.M200764200","journal-title":"Journal of Biological Chemistry"},{"key":"4391_CR16","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S0092-8674(00)81717-1","volume":"95","author":"AK Shiau","year":"1998","unstructured":"Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL: The structural basis of estrogen receptor\/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 1998, 95: 927\u2013937. 10.1016\/S0092-8674(00)81717-1","journal-title":"Cell"},{"key":"4391_CR17","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/(SICI)1097-0134(19980815)32:3<350::AID-PROT10>3.0.CO;2-8","volume":"32","author":"JN Champness","year":"1998","unstructured":"Champness JN, Bennett MS, Wien F, Visse R, Summers WC, Herdewijn P, de Clerq E, Ostrowski T, Jarvest RL, Sanderson MR: Exploring the active site of herpes simplex virus type-1 thymidine kinase by X-ray crystallography of complexes with aciclovir and other ligands. Proteins 1998, 32: 350\u2013361. 10.1002\/(SICI)1097-0134(19980815)32:3<350::AID-PROT10>3.0.CO;2-8","journal-title":"Proteins"},{"key":"4391_CR18","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1021\/jm061035y","volume":"50","author":"HB Zhou","year":"2007","unstructured":"Zhou HB, Sheng S, Compton DR, Kim Y, Joachimiak A, Sharma S, Carlson KE, Katzenellenbogen BS, Nettles KW, Greene GL, et al.: Structure-guided optimization of estrogen receptor binding affinity and antagonist potency of pyrazolopyrimidines with basic side chains. Journal of Medicinal Chemistry 2007, 50: 399\u2013403. 10.1021\/jm061035y","journal-title":"Journal of Medicinal Chemistry"},{"key":"4391_CR19","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1021\/jm049059x","volume":"48","author":"A Manikowski","year":"2005","unstructured":"Manikowski A, Verri A, Lossani A, Gebhardt BM, Gambino J, Focher F, Spadari S, Wright GE: Inhibition of herpes simplex virus thymidine kinases by 2-phenylamino-6-oxopurines and related compounds: structure-activity relationships and antiherpetic activity in vivo. Journal of Medicinal Chemistry 2005, 48: 3919\u20133929. 10.1021\/jm049059x","journal-title":"Journal of Medicinal Chemistry"},{"key":"4391_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/prot.10232","volume":"49","author":"JW Nissink","year":"2002","unstructured":"Nissink JW, Murray C, Hartshorn M, Verdonk ML, Cole JC, Taylor R: A new test set for validating predictions of protein-ligand interaction. Proteins 2002, 49: 457\u2013471. 10.1002\/prot.10232","journal-title":"Proteins"},{"key":"4391_CR21","doi-asserted-by":"publisher","first-page":"4759","DOI":"10.1021\/jm001044l","volume":"43","author":"C Bissantz","year":"2000","unstructured":"Bissantz C, Folkers G, Rognan D: Protein-based virtual screening of chemical databases. 1. Evaluation of different docking\/scoring combinations. Journal of Medicinal Chemistry 2000, 43: 4759\u20134767. 10.1021\/jm001044l","journal-title":"Journal of Medicinal Chemistry"},{"key":"4391_CR22","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/S0968-0004(00)89080-5","volume":"20","author":"RA Sayle","year":"1995","unstructured":"Sayle RA, Milner-White EJ: RASMOL: biomolecular graphics for all. Trends in Biochemical Sciences 1995, 20: 374. 10.1016\/S0968-0004(00)89080-5","journal-title":"Trends in Biochemical Sciences"},{"key":"4391_CR23","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1093\/bioinformatics\/bth349","volume":"20","author":"AJ Saldanha","year":"2004","unstructured":"Saldanha AJ: Java Treeview--extensible visualization of microarray data. Bioinformatics 2004, 20: 3246\u20133248. 10.1093\/bioinformatics\/bth349","journal-title":"Bioinformatics"},{"key":"4391_CR24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/prot.20387","volume":"59","author":"J-M Yang","year":"2005","unstructured":"Yang J-M, Shen T-W: A pharmacophore-based evolutionary approach for screening selective estrogen receptor modulators. Proteins 2005, 59: 205\u2013220. 10.1002\/prot.20387","journal-title":"Proteins"},{"key":"4391_CR25","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/1097-0134(20000901)40:4<623::AID-PROT70>3.0.CO;2-I","volume":"40","author":"X Fradera","year":"2000","unstructured":"Fradera X, Knegtel RM, Mestres J: Similarity-driven flexible ligand docking. Proteins 2000, 40: 623\u2013636. 10.1002\/1097-0134(20000901)40:4<623::AID-PROT70>3.0.CO;2-I","journal-title":"Proteins"},{"key":"4391_CR26","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1021\/jm070079j","volume":"50","author":"Z Qin","year":"2007","unstructured":"Qin Z, Kastrati I, Chandrasena RE, Liu H, Yao P, Petukhov PA, Bolton JL, Thatcher GR: Benzothiophene selective estrogen receptor modulators with modulated oxidative activity and receptor affinity. Journal of Medicinal Chemistry 2007, 50: 2682\u20132692. 10.1021\/jm070079j","journal-title":"Journal of Medicinal Chemistry"},{"key":"4391_CR27","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/j.str.2004.09.015","volume":"12","author":"ES Manas","year":"2004","unstructured":"Manas ES, Xu ZB, Unwalla RJ, Somers WS: Understanding the selectivity of genistein for human estrogen receptor-beta using X-ray crystallography and computational methods. Structure 2004, 12: 2197\u20132207. 10.1016\/j.str.2004.09.015","journal-title":"Structure"},{"key":"4391_CR28","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/39645","volume":"389","author":"AM Brzozowski","year":"1997","unstructured":"Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson JA, Carlquist M: Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997, 389: 753\u2013758. 10.1038\/39645","journal-title":"Nature"},{"key":"4391_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10822-008-9250-3","volume":"23","author":"H Shadnia","year":"2009","unstructured":"Shadnia H, Wright JS, Anderson JM: Interaction force diagrams: new insight into ligand-receptor binding. Journal of Computer-aided Molecular Design 2009, 23: 185\u2013194. 10.1007\/s10822-008-9250-3","journal-title":"Journal of Computer-aided Molecular Design"},{"key":"4391_CR30","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1002\/pro.5560061005","volume":"6","author":"K Wild","year":"1997","unstructured":"Wild K, Bohner T, Folkers G, Schulz GE: The structures of thymidine kinase from herpes simplex virus type 1 in complex with substrates and a substrate analogue. Protein Sci 1997, 6: 2097\u20132106. 10.1002\/pro.5560061005","journal-title":"Protein Sci"},{"key":"4391_CR31","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1046\/j.1432-1327.1998.2550472.x","volume":"255","author":"S Kussmann-Gerber","year":"1998","unstructured":"Kussmann-Gerber S, Kuonen O, Folkers G, Pilger BD, Scapozza L: Drug resistance of herpes simplex virus type 1--structural considerations at the molecular level of the thymidine kinase. European Journal of Biochemistry \/FEBS 1998, 255: 472\u2013481. 10.1046\/j.1432-1327.1998.2550472.x","journal-title":"European Journal of Biochemistry \/ FEBS"},{"key":"4391_CR32","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.1021\/bi992453q","volume":"39","author":"TA Hinds","year":"2000","unstructured":"Hinds TA, Compadre C, Hurlburt BK, Drake RR: Conservative mutations of glutamine-125 in herpes simplex virus type 1 thymidine kinase result in a ganciclovir kinase with minimal deoxypyrimidine kinase activities. Biochemistry 2000, 39: 4105\u20134111. 10.1021\/bi992453q","journal-title":"Biochemistry"},{"key":"4391_CR33","doi-asserted-by":"publisher","first-page":"31967","DOI":"10.1074\/jbc.274.45.31967","volume":"274","author":"BD Pilger","year":"1999","unstructured":"Pilger BD, Perozzo R, Alber F, Wurth C, Folkers G, Scapozza L: Substrate diversity of herpes simplex virus thymidine kinase. Impact Of the kinematics of the enzyme. The Journal of Biological Chemistry 1999, 274: 31967\u201331973. 10.1074\/jbc.274.45.31967","journal-title":"The Journal of Biological Chemistry"},{"key":"4391_CR34","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1099\/0022-1317-79-9-2083","volume":"79","author":"JS Evans","year":"1998","unstructured":"Evans JS, Lock KP, Levine BA, Champness JN, Sanderson MR, Summers WC, McLeish PJ, Buchan A: Herpesviral thymidine kinases: laxity and resistance by design. The Journal of General Virology 1998, 79: 2083\u20132092.","journal-title":"The Journal of General Virology"},{"issue":"1","key":"4391_CR35","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1021\/ci020055f","volume":"43","author":"Y Pan","year":"2003","unstructured":"Pan Y, Huang N, Cho S, MacKerell AD Jr.: Consideration of molecular weight during compound selection in virtual target-based database screening. J Chem Inf Comput Sci 2003, 43(1):267\u2013272.","journal-title":"J Chem Inf Comput Sci"},{"key":"4391_CR36","doi-asserted-by":"publisher","first-page":"21692","DOI":"10.1074\/jbc.M010223200","volume":"276","author":"M Sulpizi","year":"2001","unstructured":"Sulpizi M, Schelling P, Folkers G, Carloni P, Scapozza L: The rational of catalytic activity of herpes simplex virus thymidine kinase. a combined biochemical and quantum chemical study. The Journal of Biological Chemistry 2001, 276: 21692\u201321697.","journal-title":"The Journal of Biological Chemistry"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2105-12-S1-S33.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T13:46:29Z","timestamp":1630503989000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/1471-2105-12-S1-S33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,15]]},"references-count":36,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["4391"],"URL":"https:\/\/doi.org\/10.1186\/1471-2105-12-s1-s33","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,15]]},"assertion":[{"value":"15 February 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"S33"}}